These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29322188)

  • 1. Management of Morgellons Disease With Low-Dose Trifluoperazine.
    Yan BY; Jorizzo JL
    JAMA Dermatol; 2018 Feb; 154(2):216-218. PubMed ID: 29322188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morgellons disease treatment with quetiapine.
    Carrillo de Albornoz Calahorro CM; López-Delgado D; Gutiérrez-Rojas L
    Med Clin (Barc); 2019 Feb; 152(3):118-119. PubMed ID: 29706457
    [No Abstract]   [Full Text] [Related]  

  • 3. Morgellons disease etiology and therapeutic approach: a systematic review.
    Beuerlein KG; Balogh EA; Feldman SR
    Dermatol Online J; 2021 Aug; 27(8):. PubMed ID: 34755952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morgellons disease: insights into treatment.
    Aung-Din D; Sahni DR; Jorizzo JL; Feldman SR
    Dermatol Online J; 2018 Nov; 24(11):. PubMed ID: 30695970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morgellons disease, or antipsychotic-responsive delusional parasitosis, in an HIV patient: beliefs in the age of the Internet.
    Freudenreich O; Kontos N; Tranulis C; Cather C
    Psychosomatics; 2010; 51(6):453-7. PubMed ID: 21051675
    [No Abstract]   [Full Text] [Related]  

  • 6. Disorder or delusion? Living with Morgellons disease.
    Simpson L; Baier M
    J Psychosoc Nurs Ment Health Serv; 2009 Aug; 47(8):36-41. PubMed ID: 19681520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morgellons disease: experiences of an integrated multidisciplinary dermatology team to achieve positive outcomes.
    Mohandas P; Bewley A; Taylor R
    J Dermatolog Treat; 2018 Mar; 29(2):208-213. PubMed ID: 28665169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable clinical presentations of secondary delusional infestation: an experience of six cases from a psychodermatology clinic.
    Altunay IK; Ates B; Mercan S; Demirci GT; Kayaoglu S
    Int J Psychiatry Med; 2012; 44(4):335-50. PubMed ID: 23885516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morgellons in dermatology.
    Harth W; Hermes B; Freudenmann RW
    J Dtsch Dermatol Ges; 2010 Apr; 8(4):234-42. PubMed ID: 19878403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The challenge of Morgellons disease: A patient with clinicopathologic correlation.
    Caputo V; Bonoldi E; Citterio A; Rongioletti F
    Clin Dermatol; 2022; 40(6):686-690. PubMed ID: 35905899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Morgellons syndrome: a disease transmitted via the media].
    Misery L
    Ann Dermatol Venereol; 2013 Jan; 140(1):59-62. PubMed ID: 23328363
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychosis, ivermectin toxicity, and "Morgellons disease".
    DeBonis K; Pierre JM
    Psychosomatics; 2011; 52(3):295-6. PubMed ID: 21565604
    [No Abstract]   [Full Text] [Related]  

  • 13. Delusional Infestation: State of the Art.
    Vulink NC
    Acta Derm Venereol; 2016 Aug; 96(217):58-63. PubMed ID: 27282746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morgellons: contested illness, diagnostic compromise and medicalisation.
    Fair B
    Sociol Health Illn; 2010 May; 32(4):597-612. PubMed ID: 20149149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choosing the appropriate pharmacotherapy for Morgellons disease: an expert perspective.
    Balogh EA; Beuerlein KG; Feldman SR
    Expert Opin Pharmacother; 2022 Apr; 23(5):527-530. PubMed ID: 35076344
    [No Abstract]   [Full Text] [Related]  

  • 16. Delusional parasitosis facilitated by web-based dissemination.
    Vila-Rodriguez F; Macewan BG
    Am J Psychiatry; 2008 Dec; 165(12):1612. PubMed ID: 19047336
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of Morgellons disease with pimozide therapy.
    Reid EE; Lio PA
    Arch Dermatol; 2010 Oct; 146(10):1191-3. PubMed ID: 20956673
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous immunoglobulin for refractory cutaneous dermatomyositis: a retrospective analysis from an academic medical center.
    Femia AN; Eastham AB; Lam C; Merola JF; Qureshi AA; Vleugels RA
    J Am Acad Dermatol; 2013 Oct; 69(4):654-7. PubMed ID: 24034377
    [No Abstract]   [Full Text] [Related]  

  • 19. The quinacrine experience in a population of patients with cutaneous lupus erythematosus and dermatomyositis.
    Mittal L; Werth VP
    J Am Acad Dermatol; 2017 Aug; 77(2):374-377. PubMed ID: 28711090
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid improvement of prurigo nodularis with cyclosporine treatment.
    Wiznia LE; Callahan SW; Cohen DE; Orlow SJ
    J Am Acad Dermatol; 2018 Jun; 78(6):1209-1211. PubMed ID: 29438756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.